P
PRLD
Prelude Therapeutics Inc
4.090
-0.180-4.22%After Hours: 4.390 +0.300 +7.34%19:06 05/26 EDT
OPEN/PREV CLOSE4.138/4.270
TODAY RANGE4.030-4.310
VOL311.10K
MARKET CAP325.75M
52 WEEK RANGE0.7500-5.54
AVG VOL (3M)379.29K
% TURNOVER0.39%
TURNOVER--
P/E (TTM)-4.0802
% RANGE6.56%
EPS(TTM)-1.0024
P/E(FORWARD)-6.2923
P/B4.283
BVPS0.9550
DIVIDEND--
P/S21.21
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP180.58M
SHARES OUTSTANDING79.65M
NEXT EARNINGS08/12-08/17
FREE FLOAT44.15M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/16 14:20
Prelude Therapeutics Incorporated (NASDAQ:PRLD) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
TipRanks·05/15 09:13
Prelude Therapeutics initiated with Early-Stage Biotech at Goldman Sachs
Simply Wall St·05/13 22:50
Prelude Therapeutics (PRLD) Losses Narrow In Q1 2026 Challenging Bearish Narratives
TipRanks·05/12 12:04
Prelude Therapeutics Launches Phase 1 Trial and Extends Runway
Seeking Alpha·05/12 11:34
Prelude Therapeutics GAAP EPS of -$0.13 beats by $0.12, revenue of $4.58M
Reuters·05/12 11:13
Prelude Therapeutics Q1 net loss narrows as expenses fall
Dow Jones·05/12 11:02
*Prelude Therapeutics 1Q Rev $4.58M >PRLD
Dow Jones·05/12 11:02
*Prelude Therapeutics: Current Cash Runway Into 2Q 2028 >PRLD
Dow Jones·05/12 11:01
*Prelude Therapeutics 1Q Loss $10.4M >PRLD
Dow Jones·05/04 14:08
Prelude Therapeutics Initiated at Buy by D. Boral Capital
Dow Jones·05/04 14:08
Prelude Therapeutics Price Target Announced at $9.00/Share by D. Boral Capital
TipRanks·05/04 11:35
Prelude Therapeutics initiated with a Buy at D. Boral Capital
Same Industry
Name/Symbol
Change%
Price